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Reactive oxygen species
NF-κBIntracellular redox state has been suggested to have various effects on the replication of different viruses
within host cells. The aim of the present study was to investigate the inﬂuence of reactive oxygen species
(ROS) on replication of porcine circovirus type 2 (PCV2), in PK15 cells. Following PCV2 infection there was
a time-dependent increase in ROS. Antioxidant N-acetyl-L-cysteine treatment of cells resulted in lower
ROS levels and lower PCV2 replication. In contrast, treatment by buthionine sulfoximine (BSO), a GSH
synthesis inhibitor, resulted in elevation of ROS levels and increased PCV2 replication. Furthermore, inhi-
biting the activity of NF-κB, a redox-responsive transcription factor, suppressed BSO-mediated increase of
PCV2 replication, indicating that increased PCV2 replication likely occurs via ROS activation of NF-κB.
Taken together, our results indicate that the generation of ROS during PCV2 infection is involved in its
replication and this progression is associated with the alteration in NF-κB activity induced by ROS.
© 2012 Elsevier Inc. All rights reserved.Introduction
Porcine circovirus (PCV) is classiﬁed in the genus Circovirus of the
family Circoviridae (Todd et al., 2005). Two genotypes of PCV have
been identiﬁed. PCV type 1 (PCV1), which was ﬁrst recognized in
1974 as a contaminant of a continuous porcine kidney cell line
(PK15) (Tischer et al., 1982), is known to be non-pathogenic to pigs
(Allan et al., 1995). Infection with PCV type 2 (PCV2) has been associ-
ated with postweaning multisystemic wasting syndrome (PMWS) in
young weaned pigs, a disease ﬁrst recognized in Canada in 1991
(Clark, 1997). Usually PMWS appears in pigs at the age of 5 to
18 weeks and affected pigs show fever, wasting or unthriftiness, respi-
ratory distress, enlarged lymph nodes and, occasionally, jaundice and
diarrhea (Darwich et al., 2004; Segales and Domingo, 2002). Mortality
rates may vary from 1% to 2% up to 30% in complicated cases when co-
infections with porcine reproductive and respiratory syndrome virus,
porcine parvovirus, or Mycoplasma hyopneumoniae. Several studies
have suggested that severely PMWS affected pigs may develop immu-
nosuppression (Segales et al., 2004). Nowadays, PMWS and other re-
lated PCV2-associated diseases are occurring in all swine-producing
areas of the world and have become increasingly serious threats to
global pig production (Allan and Ellis, 2000; Allan et al., 1998; Choi
et al., 2000; Fenaux et al., 2000; Grau-Roma et al., 2011; Mankertz et
al., 2000; Patterson and Opriessnig, 2010). However, not all pigs
infected with PCV2 will develop PMWS. Even if PMWS occur, severity
of the disease is different in different pig farms. Obviously, infection ofrights reserved.pigs with PCV2 and other infectious/noninfectious triggers are re-
quired for PMWS to occur (Grau-Roma et al., 2011; Patterson and
Opriessnig, 2010). Several studies have linked PMWS expression to
management measures, presence of concurrent viral infections, stim-
ulation of the immune system, nutrition, male castration and lower
piglet weight at weaning (Grau-Roma et al., 2011), but the pathogenic
mechanism of PCV2 remains poorly understood.
Oxidative stress results from an imbalance between ROS produc-
tion and anti-oxidant activity conferred by enzymes such as the thior-
edoxin, reductases, glutathione peroxidases and glutathione
reductase (Schafer and Buettner, 2001). Viral infection is often ac-
companied by alteration of intracellular redox state (Baruchel and
Wainberg, 1992; Casola et al., 2001; Jamaluddin et al., 2009;
Korenaga et al., 2005; Seet et al., 2009; Wang et al., 2001; Waris et
al., 2005). Infection by the HIV is associated with decreased levels of
GSH and increased production of ROS (Ciriolo et al., 1997; Garaci et
al., 1997; Palamara et al., 1995). Additionally, the viral TAT protein in-
creases intracellular ROS levels by inhibiting the antioxidant enzyme
manganese superoxide dismutase (Flores et al., 1993). Direct interac-
tion of core protein with mitochondria is an important cause of the
oxidative stress seen in chronic hepatitis C (Korenaga et al., 2005).
ROS have also been shown to affect viral replication, promoting HIV
replication (Baruchel and Wainberg, 1992; Staal et al., 1990) but
being associated with lower bovine leukemia virus proviral loads
(Bouzar et al., 2009). However, there is no information available con-
cerning the production of ROS induced by PCV2 infection and the ef-
fects of ROS on PCV2 replication, which may contribute to interpret
why there are different incidences of PMWS in different pig farms
with PCV2 infection.
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tion of viruses through different mechanism within host cells accord-
ing to previous studies. Inhibition of inﬂuenza infection by GSH
appears to occur via GSH-dependent inhibition of apoptosis which
may slow virus release (Cai et al., 2003). Increased HIV replication
likely occurs via ROS activation of NF-κB (Korenaga et al., 2005).
However, a mechanism of action on Sendai virus replication is not
known (Ciriolo et al., 1997). It has been reported that NF-κB activa-
tion occurs principally in virus infected cells through a direct mecha-
nism because a co-localization of ORF1 protein with nuclear
translocation of p65 was detected in the PCV2-infected cells but not
in UV-irradiated PCV2-infected cells (Wei et al., 2008). However, it
is still unclear whether activation of NF-κB as an oxidant sensitive
pathway contributes to PCV2 replication in the host cells.
The present study was performed to investigate whether PCV2
infection is accompanied by alteration of ROS generation, whether
PCV2 replication in PK15 cells is affected by intracellular ROS and
whether PCV2 replication is affected by the activation of oxidant
sensitive NF-κB pathways.
Results
PCV2 infection of PK15 cells induces ROS production
To determine whether PCV2 infection induced ROS production,
PK15 cells were infected with PCV2 at MOI of 1 at different time
points. At the same end time point DCFH-DA was added to cultures
and incubated for 30 min at 37 °C. Fluorescence was measured within
60 min according to the manufacturer's instruction. When compared
with controls, a signiﬁcant production of ROS was observed at differ-
ent time points after infection, reaching a plateau at around 72 h
(Fig. 1B). At 96–120 h post infection, ROS levels had declined from
the maximum level but were still elevated above those in untreated
cells. As a positive control for DCF-DA oxidation, PK15 cells exposed
to 100 μM ROSUP (Beyotime, China) for 20 min also exhibited a sig-
niﬁcant increase over un-stimulated cells (data not shown). These re-
sults demonstrate that ROS are produced following PCV2 infection.
Reduction of ROS levels induced by NAC can decrease PCV2 replication
The ﬁnding that ROS are generated during PCV2 infection
prompted us to examine whether decreasing the production of ROSFig. 1. Time course of ROS production after PCV2 infection, BSO and NAC treatments.
(A, B) PK15 cells were infected with PCV2 at MOI of 1 at different time points. At the
same end time point DCFH-DA was added to cultures and incubated for 30 min at
37 °C. Fluorescence was measured within 60 min at 485 nm for excitation and
530 nm for emission. (C, D) PK15 cells were treated with 50 μM BSO or 5 mM NAC at
different time points. At the same end time point PK15 cells were loaded with DCFH-
DA and ﬂuorescence was measured within 60 min. Values shown are means±SD
from four independent experiments. Groups were compared by a 1-way ANOVA fol-
lowed by least-signiﬁcant difference test (*Pb0.05, **Pb0.01).would alter PCV2 replication. Firstly, cells were treated with the anti-
oxidant NAC, a precursor in glutathione synthesis which can promote
the generation of cysteine and indirectly increase glutathione levels.
PK15 cells were seeded at a density of 1×104/well in 96-plate and in-
cubated with NAC (5 mM) at different time points. At the same end
time point PK15 cells were collected for measuring DCFH-DA oxida-
tion. ROS levels were signiﬁcantly decreased at 24–120 h after
5 mM NAC treatment compared with control cells (Fig. 1). After incu-
bation with 1, 3 and 5 mM NAC for 72 h, ROS levels were reduced sig-
niﬁcantly when compared with control cells (Fig. 2A). After PK15 cells
were incubated with various concentration of NAC for 24 h before
PCV2 infection and for a further 72 h, ROS levels were increased
when compared with uninfected cells but were lower when com-
pared to infected control cells (Fig. 2A). These results indicate that
ROS levels were lowered by NAC.
To determine whether reduction of ROS levels play any role in the
replication of PCV2, the effects of NAC on PCV2 replication were eval-
uated. PK15 cells were seeded in 24-well cell culture plates and cul-
tured overnight with various concentration of NAC before PCV2
infection at MOI of 1 and incubation with NAC for 72 h. ResultsFig. 2. Reduction of ROS levels induced by NAC decreases PCV2 replication. (A) ROS
levels in NAC-treated PK15 cells at 72 h were determined with DCFH-DA. For the
PCV2-infected groups, PK15 cells were incubated with various concentration of NAC
for 24 h before PCV2 infection and then incubated with NAC for a further 72 h. Fluores-
cence was measured within 60 min at 485 nm for excitation and 530 nm for emission.
Values shown are means±SD mean from four independent experiments. (B/C) PK15
cells were cultured overnight with various concentration of NAC before PCV2 infection.
PCV2-infected PK15 cells at 72 h in the presence of various concentration of NAC were
assayed for the viral DNA copies by real-time PCR and the amount of infected cells by
IFA. Values shown are means±SD mean from three independent experiments. Aster-
isks indicate groups statistically signiﬁcantly different from control by a 1-way
ANOVA followed by least-signiﬁcant difference test (*Pb0.05, **Pb0.01).
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tion as measured by PCV2 DNA copies and the number of infected
cells (Figs. 2 and 3). The PCV2 log10 DNA copies signiﬁcantly de-
creased (Fig. 2B) and the percentage of PCV2 infected cells dropped
by 74%, 61% and 55% after 72 h incubation with 1, 3 and 5 mM NAC
respectively when compared with the control cells (Figs. 2C, 3). A
high titer viral stock solution was treated with NAC at 5 mM for 1 h
at 37 °C to determine whether NAC affected infectivity and replica-
tion of virus. No effect of NAC treatment on virus infectivity was ob-
served when these cells were compared with a mock treatment
control (data not shown), indicating that NAC is not directly inacti-
vating the virus. Overall, the results suggest reduction of ROS levels
induced by NAC decreases viral replication.Elevation of ROS levels induced by BSO can increase PCV2 replication
Data presented in Figs. 1 and 2 suggest that elevated GSH, result-
ing from incubation with antioxidant NAC, decreases the level of
viral DNA copies and the number of infected cells. Therefore, we test-
ed for the converse effect: does lower antioxidant activity accelerate
viral replication? To address this question, intracellular ROS levels
were increased by the compound BSO, which can cause irreversible
inhibition of GSH biosynthesis and decrease the capacity to detoxify
ROS. PK15 cells were seeded at a density of 1×104/well in 96-plate,
incubated with BSO (50 μM) at different time points, and ROS levels
measured by DCFH-DA oxidation. When compared with control
cells, a signiﬁcant increase of ROS levels was observed at different
time points after 50 μM BSO treatment (Fig. 1). After incubation
with BSO at different concentrations for 72 h, ROS levels were elevat-
ed signiﬁcantly when compared with control cells (Fig. 4A). After
PK15 cells were incubated with various concentrations of BSO for
24 h before PCV2 infection and then incubated with BSO for a further
72 h, ROS levels were increased when compared with uninfected and
infected control cells (Fig. 4A). These results imply that ROS levels
were increased as a result of BSO treatment.Fig. 3. Assay of infected cells by indirect ﬂuorescence assay (IFA). PCV2-infected cells wer
group, (B) control cells stained for PCV2, (C) 5 mM NAC-treated group, (D) 50 μM BSO-treat
for PCV2 viral antigens were counted in six ﬁelds of view and number of positive cells calcul
alone (data shown in Fig. 2C, Fig. 4C and Fig. 6B).To investigate whether elevation of ROS levels play any role in the
replication of PCV2, the effects of BSO exposure on PCV2 replication in
PK15 cells were evaluated. PK15 cells were seeded in 24-well cell cul-
ture plates and cultured for overnight with various concentrations of
BSO before PCV2 infection at MOI of 1 and incubated with BSO for a
further 72 h before determination of PCV2 replication and infection.
The results presented in Fig. 3 indicate that BSO treatment led to an in-
creased progression of the infection as measured by the appearance of
PCV2DNA copies and infected cells. The PCV2 log10DNA copies signif-
icantly increased and the fold increases in numbers of PCV2 infected
cells were 1.15, 1.28 and 1.41 after 72 h incubation with 10, 30 and
50 μM BSO respectively when compared with the control cells
(Figs. 4C, 3). A high titer viral stock solution was treated with BSO at
50 μM for 1 h at 37 °C to determine if BSO directly affected virus infec-
tivity and replication; a mock treatment served as a control. No effect
of BSO treatment on virus infectivity was observed (data not shown),
showing that BSO did not directly activate the virus but may affect
some aspect of viral replication. Overall, these results indicate that
the elevation of ROS levels induced by BSO increases viral replication.
Effect of BSO and NAC treatment on the activation of
NF-κB-dependent luciferase
It has been reported that PCV2 infection can activate NF-κB via
IκBα phosphorylation and degradation in PK15 cells, and the activa-
tion of NF-κB is required for virus replication and PCV2-induced apo-
ptosis (Wei et al., 2008). Since NF-κB activity is susceptible to be
regulated by alterations in the intracellular redox state, it is possible
that the effect of NAC and BSO treatment on PCV2 replication is asso-
ciated with alteration in NF-κB activity induced by ROS. To address
this question, we determined NF-κB activation by measuring pNF-
κB-luc-reporter gene expression in transiently transfected PK15 cells
treated with PCV2 infection, NAC or BSO. As shown in Fig. 5, luciferase
activity in PCV2-infected PK15 cells was 244% of that found in unin-
fected control cells, indicating an activation of NF-κB by PCV2 infec-
tion. Luciferase activity in BSO-treated cells was lower, showing ae detected by immunoﬂuorescence (10×20 magniﬁcation). (A) Non-infected control
ed group and (E) 10 μM BAY 11-7082 treated groups all stained for PCV2. Cells positive
ated as percentages of PCV2-positive cells compared to control cells infected with PCV2
Fig. 4. Elevation of ROS levels induced by BSO increases PCV2 replication. (A) ROS
levels in BSO-treated PK15 cells at 72 h were determined with DCFH-DA. Fluorescence
was measured within 60 min at 485 nm for excitation and 530 nm for emission. For the
PCV2-infected groups, PK15 cells were incubated with various concentration of BSO for
24 h before PCV2 infection and then incubated with NAC for a further 72 h. Values
shown are means±SD from four independent experiments. (B/C) PK15 cells were cul-
tured overnight with various concentration of BSO before PCV2 infection. PCV2-
infected PK15 cells at 72 h in the presence of various concentration of BSO were
assayed for the viral DNA copies by real-time PCR and the amount of PCV2 viral antigen
by IFA. Values shown are means±SD mean from three independent experiments. As-
terisks indicate groups statistically signiﬁcantly different from control by a 1-way
ANOVA followed by least-signiﬁcant difference test (*Pb0.05, **Pb0.01).
Fig. 5. Effect of BSO and NAC treatment on ROS levels and activation of NF-kB-
dependent luciferase. PK15 cells were seeded at a density of 5×103/well in 96-well
plates one day prior to transfection for 6 h with pNF-κB-luc containing NF-κB binding
motifs (GGGAATTTCC). The cells were washed and then cultured in 100 μl DMEM
with 5% FBS for 24 h before infection with PCV2 at MOI of 1 and incubated with various
concentrations of BSO or NAC for 72 h. (A) Effect of BSO and NAC treatment on ROS
levels was determined with DCFH-DA. Fluorescence was measured within 60 min at
485 nm for excitation and 530 nm for emission. (B) Activity of NF-κB-dependent lucif-
erase of cell extracts from each sample was measured using a luciferase assay kit
according to the manufacturer's protocol. Activation of NF-κB-dependent luciferase
was recorded as a percentage of mock infection. Values shown are means±SD from
three independent experiments. Asterisks indicate groups statistically signiﬁcantly dif-
ferent from control by a 1-way ANOVA followed by least-signiﬁcant difference test
(*Pb0.05, **Pb0.01).
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BSO treatment, as compared with untreated controls. But luciferase
activity in PCV2-infected cells showed an increase of 268%, 290% and
304%, respectively after 10, 30 and 50 μMBSO treatment, as compared
with untreated controls. In contrast, after 1, 3 and 5 mM NAC treat-
ment, NF-κB activity in infected or non-infected PK15 cells decreased
signiﬁcantly when compared to untreated PK15 cells. Furthermore,
both the patterns andmagnitudes of increased or decreased luciferase
activity were similar to that of ROS levels in PK15 cells with the same
treatments. These results indicate that NF-κB activation could be in-
duced by PCV2 infection and is closely associated with ROS levels in
host cells after BSO and NAC treatment.
Inhibition of NF-κB activation suppresses BSO-mediated increase in PCV2
replication
BAY 11-7082 ((E)-3-[4-methylphenylsulfonyl]-2-propenenitrile)
is widely used as an inhibitor of cytokine-induced IκBα phosphoryla-
tion and consequently as an agent which results in decreased expres-
sion of NF-κB (Hernandez-Garcia et al., 2010). To conﬁrm therelationship between NF-κB and ROS-mediated viral replication,
PK15 cells were treated with 10 μM BAY 11-7082 for 5 h. After 5 h
of BAY 11-7082 treatment, the medium was removed, and fresh
basal medium containing fresh inhibitor BAY 11-7082 and BSO was
added to the culture. 24 h later, the PK15 cells were then infected
with PCV2 and incubated with BAY 11-7082 and BSO for 72 h prior
to determination. The results presented in Fig. 6 indicate that BSO-
mediated increase in PCV2 replication was suppressed by BAY 11-
7082 treatment as measured by the number of PCV2 DNA copies
and infected cells. After 72 h incubation with 10, 30 and 50 μM BSO
alone, the percentage of PCV2 infected cells increased when com-
pared with the control cells, but after BAY 11-7982 treatment and
72 h incubation with BSO, the percentage of PCV2 infected cells
dropped by 62%, 74% and 77% when compared to the control
(Figs. 6B, 3). After BAY 11-7982 treatment, the percentage of PCV2
infected cells decreased signiﬁcantly when compared to cells without
BAY 11-7982 treatment at the same concentration of BSO. These re-
sults indicate that inhibition of NF-κB activation suppresses BSO-
mediated increase in PCV2 replication.
Discussion
The intracellular redox state is the result of a dynamic equilibrium
between oxidant and antioxidant molecules. It has been suggested to
affect viral replication within a host cell (Ciriolo et al., 1997; Garaci et
al., 1997; Michalek et al., 2008; Staal et al., 1990). Results from the
Fig. 6. Inhibition of NF-κB activation suppresses BSO-mediated increase in PCV2 repli-
cation. After 5 h of treatment with 10 μM BAY 11-7082, PK15 cells were cultured over-
night with various concentration of BSO in the presence of 10 μM BAY 11-7082 before
PCV2 infection. PCV2-infected PK15 cells at 72 h in the presence of 10 μM BAY 11-7082
and various concentrations of BSO were assayed for the viral DNA copies by real-time
PCR (A) and the amount of infected cells by IFA (B). Values shown are means±SD
from three independent experiments. Within the groups with/without BAY 11-7082
treatment, bars with “*” are statistically signiﬁcantly different from control (0 μM
BSO) by oneway ANOVA followed by least-signiﬁcant difference test (*Pb0.05,
**Pb0.01). “x” and “xx” denote signiﬁcant difference (xPb0.05, xxPb0.01) between
treated cells and untreated cells by BAY 11-7082.
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duction in PK15 cells. First, antioxidant NAC treatment of cells
resulted in reduction of ROS levels and an inhibitory effect on virus
growth. Second, BSO treatment of cells resulted in elevation of ROS
levels and increased number of viral DNA copies and infected cells.
Since NF-κB is a factor activated in response to cellular stress, includ-
ing oxidative stress (Morgan and Liu, 2011), these results raised the
possibility that effect of NAC and BSO treatment on PCV2 replication
would be associated with alteration in NF-κB pathway induced by
ROS. To test this hypothesis we used a reporter gene assay to deter-
mine the NF-κB activity after PCV2 infection, NAC and BSO treatment.
NF-κB activity increased in PCV2-infected or BSO-treated PK15 cells
while it decreased in NAC-treated PK15 cells when compared with
control cells. These results indicate that NF-κB activation could be in-
duced by PCV2 infection and is closely associated with ROS levels in
host cells after BSO and NAC treatment. The involvement of NF-κB
regulation in ROS-mediated PCV2 replication was supported further
by the effects of the IκBα phosphorylation inhibitor BAY 11-7982.
Overall these data provide the ﬁrst report of an association between
increased ROS production in PK15 cells and PCV2 infection and they
demonstrate that intracellular ROS level play a role in PCV2 replica-
tion and this progression is associated with the alteration in activa-
tion of the NF-κB pathway induced by ROS.
Porcine circovirus type 2 is found worldwide in pigs and has been
linked to several pathological conditions collectively named porcine
circovirus diseases (PCVD) (Allan and Ellis, 2000; Allan et al., 1998;
Gillespie et al., 2009). The most economically important PCVD is
post-weaning multisystemic wasting syndrome (PMWS), which re-
sults in losses of €900 million per year in the European Union
(Armstrong and Bishop, 2004). However, not all pigs infected withPCV-2 will develop PMWS even though PCV2 is recognized as an es-
sential infectious agent of PMWS (Grau-Roma et al., 2011). Infection
of pigs with PCV2 and other unknown triggers are required for
PMWS to occur (Grau-Roma et al., 2011). Evaluation of the role of
these triggers is essential in order to understand the incidence of
PMWS. Previous studies have demonstrated that some viruses, such
as HIV, inﬂuenza, RSV and LCMV, can promote ROS generation during
infection and ROS have also been shown to promote viral replication
and immuno-suppression (Baruchel and Wainberg, 1992; Casola et
al., 2001; Jamaluddin et al., 2009; Korenaga et al., 2005; Seet et al.,
2009; Wang et al., 2001; Waris et al., 2005). In contrast, the levels
of ROS inversely correlated with bovine leukemia virus proviral
loads (Bouzar et al., 2009) and glutathione is required for efﬁcient
production of infectious picornavirus virions (Smith and Dawson,
2006). The present observations that elevation of ROS is a direct con-
sequence of PCV2 infection, and that PCV2 replication can be affected
by ROS levels after BSO and NAC treatment, suggest that redox factors
contribute to the complex interrelationship between PCV2 and por-
cine circovirus associated diseases.
The results presented here for PCV2 are consistent with those
obtained with HIV and Sendai virus where BSO treatment increased
virus replication and NAC treatment decreased virus replication
(Garaci et al., 1997; Macchia et al., 1999). In addition, it has been sug-
gested that oxidative stress caused by elevated inﬂammatory cyto-
kines and decreased GSH-dependent antioxidant functions in HIV
infection promotes the activation of NF-κB and replication of HIV,
resulting in the disease progression associated with the CD4+ T-
cell loss, immunodeﬁciency, and opportunistic infection (Nakamura
et al., 2002). Inﬂuenza replication is inhibited by GSH and is enhanced
when GSH levels are reduced (Cai et al., 2003). The intracellular GSH
levels decrease during inﬂuenza virus infection and the more oxida-
tive environment established by the inﬂuenza virus's depletion of
GSH would increase the expression and oxidation of protein disulﬁde
isomerase in the endoplasmic reticulum, accelerating disulﬁde bond-
ing and enhancing viral glycoprotein maturation, which is supported
by the fact that BSO treatment signiﬁcantly decreased intracellular
GSH levels and increased HA expression and viral titers in cell super-
natants (Sgarbanti et al., 2011). Our results demonstrate that effect of
BSO and NAC on PCV2 replication is associated with the alteration in
NF-κB pathway induced by ROS.
In conclusion, our results demonstrate that the PCV2 infection and
replication not only generate ROS but also is affected by redox state,
and that this progression is associated with the alteration in NF-κB
pathway induced by oxidative stress. Our research may contribute
to interpret the incidence of PMWS when oxidative stress from
other unknown triggers is present. Future studies targeting effect of
ROS on PCV2 replication in vivo and in vitro may lead to improving
treatment of PCV2-associated diseases and production of PCV2
vaccine.Materials and methods
Reagents and antibodies
Buthionine sulfoximine (BSO) was purchased from Sigma. N-
acetyl-L-cysteine (NAC) and (E)-3-[4-methylphenylsulfonyl]-2-pro-
penenitrile (BAY 11–7082) were purchased from Beyotime Institute
of Biotechnology, China. The cytotoxicity of BSO, NAC and inhibitor
BAY 11-7082 on PK15 cells was determined by trypan blue exclusion
dye staining. It was noted that throughout all doses of BSO, NAC and
inhibitor BAY 11-7082 used in the present study, cell viability assay
showed no detectable cell death in the PK15 cells. Porcine anti-
PCV2 antibody for immunoﬂuorescence was purchased from Univ
Biotech Co. Ltd., China. FITC-linked secondary antibody (rabbit anti-
pig IgG) was purchased from Sigma.
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PK-15 cells (porcine kidney) were provided by China Institute of
Veterinary Drug Control and free of PCV1. PK-15 cells were propagat-
ed at 37 °C in an atmosphere of 5% CO2 in DMEM (Invitrogen, USA)
supplemented with 5% FBS, penicillin (20 mg/ml), streptomycin
(20 mg/ml), referred hereafter as the culture medium. The wild-
type PCV2 (PCV2NJ2002) used in the experiment was isolated origi-
nally from a kidney tissue sample of a pig with naturally occurring
PMWS. The determination of PCV type was performed by sequencing
(Invitrogen, USA). PCV2 stocks were generated from PK-15 cells
infected with PCV2 according to the following procedure: PK-15
cells were infected with PCV2 at a multiplicity of infection (MOI) of
1, when cells had reached approximately 40%–50% conﬂuence. After
1 h absorption, the inoculum was removed, and the cell monolayer
was washed three times with phosphate-buffered saline (PBS).
DMEM medium including 5% FBS, penicillin (20 mg/mL) and strepto-
mycin (20 mg/mL), was subsequently added, and incubation was
continued at 37 °C with 5% CO2 for 72 h. Then the infected cells
were subcultured in DMEM and the PCV2 was serially passaged in
PK-15 cells. The virus harvested at each passage was stored at
−80 °C.
SYBR green real-time PCR for the quantiﬁcation of PCV2 DNA copies
Newly synthesized viral DNA in PK15 cell culture was assayed by
SYBR green real-time PCR as described elsewhere (Pan et al., 2008).
Brieﬂy, the PCV2 infected PK15 cells were harvested at 72 h post-
inoculation and DNA extractions were carried out using the TaKaRa
DNA Mini kit (TaKaRa, China). The puriﬁed DNA was used as tem-
plates for real-time PCR ampliﬁcation. A region of 117 bp was ampli-
ﬁed from the PCV2 ORF2 gene with a pair of PCV2 speciﬁc primers
(Forward primer: 5′-TAGTATTCAAAGGGCACAG-3′, Reverse primer:
5′-AAGGCTACCACAGTCAG-3′). Quantitative real-time PCR was car-
ried out using the ABI PRISM 7300 Detection System (Applied Biosys-
tems, USA). A recombinant pMD19 plasmid vector (TaKaRa, China)
containing PCV2 genome insert was used as standard reference. The
viral DNA quantity was detected using the TaKaRa SYBR Green qPCR
Kit (TaKaRa, China).
Assay of infected cells by indirect ﬂuorescence assay (IFA)
After 72 h post-inoculation, PK15 cells were ﬁxed in methanol and
washed with phosphate-buffered saline (PBS). After ﬁxation, the cells
were blocked by PBS with 2% BSA at room temperature for 1 h. The
porcine anti-PCV2 antibody (Univ Biotech, China), diluted in PBS con-
taining 1% BSA (PBSB) (1:50), was added to the cells and incubated at
37 °C for 1 h. After washing with PBS containing 0.1% Tween-20, an
optimum dilution (1:100) of FITC-conjugated rabbit anti-pig antibody
(Sigma, USA) was added and incubated for 1 h at 37 °C. After wash-
ing, the cells were examined under a ﬂuorescence microscope. Cells
positive for PCV2 viral antigens were counted in six ﬁelds of view.
Fluorescence assay of ROS
Assay of intracellular ROS were measured with 2′, 7′-dichloro-
ﬂuorescein diacetate (DCFH-DA; Beyotime, China) (Hernandez-
Garcia et al., 2010). DCFH-DA passively diffuses into cells and is dea-
cetylated by esterases to form nonﬂuorescent 2′, 7′-dichloroﬂuores-
cein (DCFH) which in the presence of ROS forms the ﬂuorescent
product DCF, which is trapped inside the cells. PK15 cells were seeded
at a density of 1×104/well in 96-plate (Corning, USA). 5 h after seed-
ing, the culture wells were infected with PCV2 at MOI of 1 and incu-
bated with various concentrations of BSO or NAC for 72 h. To obtain
dissociated PK15 cells for the ROS assay, culture medium was ﬁrst re-
moved and the cells were washed three times with PBS. DCFH-DA,diluted to a ﬁnal concentration of 10 μM with a serum free DMEM,
was added to cultures and incubated for 30 min at 37 °C. The ﬂuores-
cence was measured at 485 nm for excitation and 530 nm for emis-
sion with a ﬂuorescence plate reader (TECAN inﬁnite M200, TECAN).
pNF-κB-luc transfection and luciferase reporter assays
One day prior to transfection, PK15 cells were seeded at a density
of 5×103/well in 96-well plates (Corning, USA). The pNF-κB-luc re-
porter gene constructs (Beyotime, China) containing NF-κB binding
motifs (GGGAATTTCC) were transfected into PK15 cells using Lipofec-
ter reagents (Beyotime, China) in serum free DMEM. The cells were
washed twice with PBS and then cultured in 100 μl DMEM with 5%
FBS for 24 h. PK15 cells were infected by PCV2 at MOI of 1 or incubat-
ed with various concentrations of BSO or NAC for 72 h before deter-
mination. Activity of NF-κB-dependent luciferase of cell extracts
from each sample was measured using a luciferase assay kit according
to the manufacturer's protocol. Three independent experiments were
performed to assess luciferase activity.
Statistical analysis
Statistical analysis of the experimental data was performed using
the statistical package (SPSS) V17.0 for windows. Data were analyzed
for establishing their signiﬁcance using one-way analysis of variance
(ANOVA) followed by least-signiﬁcant difference test. Data are
expressed as means±SD. Differences were regarded as signiﬁcant
at Pb0.05.
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